CLLEAR RX LTD

Executive Summary

Cllear RX Ltd exhibits a low financial risk profile with improving liquidity, net assets, and compliance standing. Despite this, the disclosed going concern material uncertainties and reliance on a single director warrant further examination to confirm operational resilience. Overall, the company appears solvent and compliant based on the latest filed accounts and statutory returns.

CLLEAR RX LTD - Analysis Report

Company Number: 13123964

Analysis Date: 2025-07-19 13:05 UTC

1. Risk Rating: LOW

The company demonstrates a solid financial position with positive net assets and net current assets, no overdue filings, and no indication of insolvency or regulatory non-compliance. The going concern note mentions material uncertainties but concludes that the basis remains appropriate, which is typical caution rather than a red flag.

2. Key Concerns:

• Material uncertainties disclosed regarding going concern suggest potential risks to operational continuity that merit further investigation.
• Debtors balance has reduced significantly from the prior year (£42,108 to £26,624), which could imply slower collection or changes in business volume.
• The company is very small with only one employee (the director), which may raise operational sustainability concerns if the business depends heavily on a single individual.

3. Positive Indicators:

• Strong improvement in net current assets from £21,352 to £32,142 indicates increased liquidity and working capital.
• Net assets increased from £26,051 to £34,712, reflecting retained earnings growth and financial strengthening.
• No overdue statutory filings (accounts and confirmation statement) indicate good compliance and governance.
• Cash at bank rose from £13,402 to £20,322, enhancing short-term liquidity.
• The company is classified under "Total Exemption Full" accounts and remains a small company, reducing complexity and risk of financial distress.

4. Due Diligence Notes:

• Clarify the nature of the material uncertainties noted in the going concern disclosure and management’s plans to mitigate these risks.
• Review aging analysis and quality of debtors, particularly given the decline in debtor balances year over year.
• Understand revenue trends and client concentration to assess operational stability given the micro scale and single employee.
• Confirm related party transactions and any potential impact on financial health or conflicts of interest.
• Investigate the ultimate controlling party (Digiteyez Corporation, USA) to assess any cross-border risks or dependencies.